AlzeCure Pharma AB (publ) (STO:ALZCUR)

Market Cap	253.96M
Revenue (ttm)	n/a
Net Income (ttm)	-39.15M
Shares Out	114.91M
EPS (ttm)	-0.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,315
Average Volume	56,975
Open	2.210
Previous Close	2.210
Day's Range	2.210 - 2.360
52-Week Range	0.812 - 4.950
Beta	-0.08
RSI	55.26
Earnings Date	Nov 11, 2025

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 11
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ALZCUR